ALREX 0.2% EYE DROPS
FDA nonproprietary name: loteprednol etabonate
For 1 mL
Pharmacies pay
$58.01 – $58.04 filed
1 × $58.01 to $58.04442 per ML (the 2 NDCs differ)
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$55.83 filed
1 × $55.82528 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.96× estimated
Medicare paid about what pharmacies pay.
Part D averages every strength and form sold under “Alrex” / “Loteprednol Etabonate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-07-22, 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$71.71 – $71.75 estimated
NADAC for the pack + 15% + $5.00 fee per fill
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-07-22, 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ALREX 0.2% EYE DROPS is how the CMS NADAC file names this product. The FDA NDC Directory lists it as loteprednol etabonate, under the trade name “Alrex”.
FDA gives its dosage form as suspension/ drops and its route as ophthalmic.
The labeler, the company named on the label, is Bausch & Lomb Incorporated.
FDA’s Established Pharmacologic Class for it is Corticosteroid.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $58.01 – $58.04 for 1 mL, depending on the NDC ($58.01 to $58.04442 per ML), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-07-22 and 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 4, carried forward from the previous file; 5, calculated based on package size.
The NADAC of 1 of these 2 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-07-22. The file is new; the price is not.
NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $30.71714 per ML filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · NADAC explanation codes · Carried-forward prices
All 2 NDCs
- 24208-0353-05 · Bausch & Lomb Incorporated · $58.04442 per ML · eff. 2026-09-23 filed
- 24208-0353-10 · Bausch & Lomb Incorporated · $58.01 per ML · eff. 2026-07-22 filed carried forward
Other strengths, forms and brands
7 other products in the NADAC file share the FDA nonproprietary name loteprednol etabonate with ALREX 0.2% EYE DROPS.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ALREX 0.2% EYE DROPS this page | $58.01 to $58.04442 per ML filed | $55.82528 per ML filed |
| EYSUVIS 0.25% EYE DROPS | $61.51166 per ML filed | $58.7776 per ML filed |
| LOTEMAX 0.5% EYE OINTMENT | $99.7438 per GM filed | $88.6467 per GM filed |
| LOTEMAX 0.5% OPHTHALMIC GEL | $49.66158 per GM filed | $88.6467 per GM filed |
| LOTEMAX SM 0.38% OPHTH GEL | $49.48461 per GM filed | $49.86513 per GM filed |
| LOTEPREDNOL 0.5% OPHTHALMC GEL | $18.18798 per GM filed | We don’t know yet |
| LOTEPREDNOL ETABONATE 0.2% DRP | $30.71714 per ML filed | We don’t know yet |
| LOTEPREDNOL ETABONATE 0.5% DRP | $10.47371 to $21.199 per ML filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $58.01 per ML filed.
Of the 106 other products in FDA’s Corticosteroid class priced per ML, 2 have a higher middle NADAC price and 104 a lower one. The one in the middle is FLUNISOLIDE 0.025% SPRAY, at $1.98777 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $55.83 for 1 mL, at an average of $55.82528 per ML in 2024 (2024-01-01 to 2024-12-31) for “Alrex” and “Loteprednol Etabonate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 16,908 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
- Which NDC (the 11-digit number on the package) is this? Pharmacies pay $58.01 to $58.04442 per ML for this product, depending on the NDC.
- Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: LOTEPREDNOL ETABONATE 0.2% DRP. Ask your pharmacist or prescriber; do not switch on your own.
- How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for ALREX 0.2% EYE DROPS labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Alrex / Loteprednol Etabonate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
- Why does this page start at 1 mL?
- The FDA package descriptions of this product’s NDCs give different amounts (5 mL, 10 mL). So the card starts at 1 ML; change it to match your prescription.
Related pages
Its pharmacologic class
Related in the same class
- PREDNISONE 1 MG TABLET
- TRELEGY ELLIPTA 100-62.5-25
- METHYLPREDNISOLONE 16 MG TAB
- PREDNISOLONE AC 1% EYE DROP
- BREO ELLIPTA 100-25 MCG INHALR